Amble Tirzepatide 7.5mg Lyophilized Powder for Weight Loss Research

Amble tirzepatide is a novel dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist developed for research purposes. This synthetic peptide mimics the action of endogenous incretins to potentially enhance insulin secretion and suppress glucagon levels in laboratory settings.

The molecular structure of amble tirzepatide features a 39-amino acid peptide backbone with specific modifications including two non-natural residues (Aib at positions 2 and 13) and a C20 fatty diacid side chain at Lys20, contributing to its extended research applications.

Available in lyophilized powder form, our amble tirzepatide is produced under strict quality control measures to ensure consistency and purity for research applications. The product is supplied in various dosage options to accommodate different experimental requirements.

For laboratory reference only, typical research protocols suggest initial testing with 2.5mg quantities, with potential incremental adjustments based on experimental outcomes. Maximum testing quantities in controlled environments may reach up to 15mg per application.

Amble tirzepatide has gained significant attention in metabolic research circles due to its dual-action mechanism as both a GLP-1 and GIP receptor agonist. These properties make it particularly interesting for studies involving glucose metabolism and energy regulation.

Our manufacturing process ensures high purity amble tirzepatide suitable for various research applications. The product undergoes multiple quality control checks including HPLC analysis to verify purity and consistency between batches.